Medtronic (MDT) Net Income towards Common Stockholders (2014 - 2026)

Medtronic's Net Income towards Common Stockholders history runs 13 years deep, the most recent figure standing at $1.2 billion for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders fell 11.74% year-over-year to $1.2 billion; the TTM figure through Jan 2026 stood at $4.6 billion (up 8.26% YoY), while the FY2025 annual figure was $4.7 billion, up 26.67% from the prior year.
• Net Income towards Common Stockholders came in at $1.2 billion for Q1 2026 at Medtronic, down from $1.4 billion in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $1.5 billion in Q2 2022 to a low of $436.0 million in Q4 2022.
• A 5-year average of $1.1 billion and a median of $1.2 billion in 2026 frame the typical range for Net Income towards Common Stockholders.
• Across the five-year window, Net Income towards Common Stockholders tumbled 66.89% in 2022 and soared 108.94% in 2023, its largest moves.
• Medtronic's Net Income towards Common Stockholders stood at $436.0 million in 2022, then jumped by 108.94% to $911.0 million in 2023, then soared by 40.29% to $1.3 billion in 2024, then gained by 8.14% to $1.4 billion in 2025, then fell by 16.79% to $1.2 billion in 2026.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $1.2 billion, $1.4 billion, and $1.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison